新冠病毒S蛋白突变|英国南非巴西突变|Biotinylated SARS-CoV-2 S protein (HV69-70del, Y144del, N501Y, A570D, D614G, P681H, T-蛋白质/抗原/多肽-试剂-生物在线
北京百普赛斯生物科技股份有限公司
新冠病毒S蛋白突变|英国南非巴西突变|Biotinylated SARS-CoV-2 S protein (HV69-70del, Y144del, N501Y, A570D, D614G, P681H, T

新冠病毒S蛋白突变|英国南非巴西突变|Biotinylated SARS-CoV-2 S protein (HV69-70del, Y144del, N501Y, A570D, D614G, P681H, T

商家询价

产品名称: 新冠病毒S蛋白突变|英国南非巴西突变|Biotinylated SARS-CoV-2 S protein (HV69-70del, Y144del, N501Y, A570D, D614G, P681H, T

英文名称: Biotinylated SARS-CoV-2 S protein (HV69-70del, Y144del, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H) trimer, His,Avitag (MALS verified)

产品编号: SPN-C82E5

产品价格: 0

产品产地: USA

品牌商标: ACROBiosystems

更新时间: null

使用范围: null

北京百普赛斯生物科技股份有限公司
  • 联系人 :
  • 地址 : 北京经济技术开发区宏达北路8号5号楼4层
  • 邮编 : 100176
  • 所在区域 : 北京
  • 电话 : 点击查看
  • 传真 : 点击查看
  • 邮箱 : order.cn@acrobiosystems.com

Biotinylated SARS-CoV-2 S protein trimer, His,Avitag (SPN-C82E5) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Pro 1213 (Accession # QHD43416.1). The recombinant protein is expressed from human 293 cells (HEK293) with T4 fibritin trimerization motif and a polyhistidine tag at the C-terminus. Proline substitutions (F817P/ A892P/ A899P/ A942P/ K986P/ V987P) and alanine substitutions (R683A and R685A) are introduced to stabilize the trimeric prefusion state of SARS-CoV-2 S protein and abolish the furin cleavage site, respectively. HV69-70del/ Y144del/ N501Y/ A570D/ D614G/ P681H/ T716I/ S982A/ D1118H/ mutations were identified on the spike protein in the SARS-CoV-2 variant (known as B.1.1.7, 20B/501Y.V1 or VOC 202012/01) which emerged in the United Kingdom.

Molecular Characterization

Molecular Weight:

139.4 kDa

Purity:

>95% as determined by SDS-PAGE.

Endotoxin:

Less than 1.0 EU per μg by the LAL method.

Bioactivity: